BDBM50063651 CHEMBL262569::N-(3-ethylesterbenzoicacid)-2-[3,4-dihydro-3-[(2,3-dichloro)-phenyl]-4-oxo-2-quinazolinyl]hydrazinecarboxamide

SMILES CCOC(=O)c1cccc(NC(=O)NNc2nc3ccccc3c(=O)n2-c2cccc(Cl)c2Cl)c1

InChI Key InChIKey=OJTIVJDODJMKGV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50063651   

TargetCholecystokinin receptor type A(Rat)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50063651(N-(3-ethylesterbenzoicacid)-2-[3,4-dihydro-3-[(2,3...)
Affinity DataIC50: 1.66E+3nMAssay Description:Binding affinity towards Cholecystokinin type A receptor (CCK-A) receptor from rat pancreas using [125I]bolton Hunter CCK-8 as radioligandMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Mouse)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50063651(N-(3-ethylesterbenzoicacid)-2-[3,4-dihydro-3-[(2,3...)
Affinity DataIC50: 50nMAssay Description:Binding affinity towards Cholecystokinin type B receptor (CCK-B) receptor in mouse cerebral cortex using [125I]bolton Hunter CCK-8 as radioligandMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed